A UCLA student is suing multiple California health care providers and hospitals for medical negligence, alleging she was ...
The U.S. Food and Drug Administration reissued a decision first made by the agency in October that a shortage of the diabetes ...
Henrik Wulff, the man in charge of product supply at Novo Nordisk, just spent $11 billion to try to fill an ocean. Novo has ...
Nestle just rolled out a new protein shot drink that it says will help people looking to lose weight manage their hunger and ...
On December 19, 2024, the U.S. Food and Drug Administration (FDA) issued a Declaratory Order reevaluating and re-confirming ...
Hims & Hers faces regulatory hurdles but shows strong business growth. Find out why HIMS stock is a "Hold" despite setbacks ...
Merck & Co. has added a second GLP-1 candidate to its pipeline, paying China’s Hansoh Pharma $112 million upfront for a ...
New research shows how weight loss meds like Wegovy are reshaping alcohol habits, offering new insights into addiction ...
News of Merck’s licensing of Hansoh’s preclinical medicine pressured shares in Viking and other obesity drug developers seen ...
On December 17, 2024, the FDA published five (5) warning letters previously issued to makers of knockoff GLP-1 drugs. Four of ...
GLP-1 drugs are remarkably effective at addressing obesity, cardiovascular, and metabolic conditions, but investigators ...
The new packaging, intended to benefit semaglutide users, will be rolled out in January — but experts say “it will be up to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback